IMPAX LABORATORIES, LLC (IPXL) financial statements (2021 and earlier)

Company profile

Business Address 30831 HUNTWOOD AVENUE
HAYWARD, CA 94544
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments182180340415413299
Cash and cash equivalents182180340215185142
Short-term investments   200229157
Receivables30225732414611392
Inventory, net of allowances, customer advances and progress billings158175126817090
Inventory158175126817090
Disposal group, including discontinued operation32     
Prepaid expense and other current assets22
Deferred tax assets   555142
Other undisclosed current assets21183234130
Total current assets:696631822730660546
Noncurrent Assets
Inventory, Noncurrent 13 1277
Property, plant and equipment125233214188188181
Intangible assets, net (including goodwill)470828812545776
Goodwill207207210282828
Intangible assets, net (excluding goodwill)262620602273048
Deferred costs 37    
Other noncurrent assets6161746458
Prepaid expense and other noncurrent assets43
Deferred tax assets, net   423419
Other undisclosed noncurrent assets 200(12)(7)(7)
Total noncurrent assets:6561,1921,100349337318
TOTAL ASSETS:1,3511,8231,9221,079997864
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities329290261176188158
Accounts payable815956322741
Accrued liabilities24823120511011293
Employee-related liabilities   342823
Taxes payable   0212
Debt1818    
Estimated litigation liability   13  
Disposal group, including discontinued operation7     
Deferred revenue and credits   146
Deferred tax liabilities   222
Other undisclosed current liabilities 1466(33)(40)(21)
Total current liabilities:354321327159154145
Noncurrent Liabilities
Long-term debt and lease obligation770814425   
Long-term debt, excluding current maturities770814425   
Liabilities, other than long-term debt376462585746
Deferred revenue and credits   346
Deferred compensation liability, classified  26262419
Other liabilities376436292921
Other undisclosed noncurrent liabilities3 47(26)(24)(19)
Total noncurrent liabilities:810878533333328
Total liabilities:1,1641,199860191187173
Stockholders' equity
Stockholders' equity attributable to parent1876241,062888810691
Common stock111111
Treasury stock, value(2)(2)(2)(2)(2)(2)
Additional paid in capital560535504364337315
Accumulated other comprehensive income (loss)1(8)(10)(6)15
Retained earnings (accumulated deficit)(372)98570531474373
Total stockholders' equity:1876241,062888810691
TOTAL LIABILITIES AND EQUITY:1,3511,8231,9221,079997864

Income statement (P&L) ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues776824860596512582
Cost of revenue
(Cost of Goods and Services Sold)
(535)(487)(508)(283)(312)(299)
Other undisclosed gross profit(97)(489)    
Gross profit:144(151)352313199283
Operating expenses(546)(343)(283)(224)(206)(200)
Operating income (loss):(403)(494)7089(6)83
Nonoperating income (expense)(7)(0)121541
Investment income, nonoperating 11111
Other nonoperating income (expense)(7)(1)00152(0)
Interest and debt expense(55)(41)(44)(0)(0)(1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes13(40)33   
Income (loss) from continuing operations before income taxes:(451)(576)599114783
Income tax expense (benefit)(18)104(20)(33)(46)(27)
Net income (loss) available to common stockholders, diluted:(469)(472)395710156

Comprehensive Income ($ in millions)

12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(469)(472)395710156
Other undisclosed comprehensive income (loss) 3(4)(7)(4)4
Comprehensive income (loss):(469)(469)35509759
Other undisclosed comprehensive income, net of tax, attributable to parent9     
Comprehensive income (loss), net of tax, attributable to parent:(460)(469)35509759

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: